← Leaderboards
Eric R Henderson
Dartmouth College
$2,461,790
Attributed
$4,319,482
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,319,482 · 4
By mechanism
R01$3,478,712 · 2
K23$678,770 · 1
R03$162,000 · 1
Top collaborators
- Summer Lynne Gibbs6 shared
- Jonathan T Elliott1 shared
- Saeed Hassanpour1 shared
Most similar at Dartmouth College
Same institution · by research overlap
- John B Weaver$4,666,036
- Jack Hoopes$5,743,238
- P. Jack Hoopes$1,097,012
- Jonathan T Elliott$3,324,833
- Saeed Hassanpour$6,314,212
Others in their field
Other Emerging Leaders on “Light”
- Peter K Fritschel · California Institute Of Technology$78,820,000
- Laura Ferrarese · Association Of Universities For Research In Astronomy, Inc.$47,742,424
- Susan Abushakra · Alzheon, Inc.$47,265,244
- James Dale Berry · Brigham And Women'S Hospital$25,017,559
- Arnab Kumar Chatterjee · Washington University$22,541,385
- Scott Fry$21,470,000
Research focus
LightTissuesVisualOperative Surgical ProceduresSurgeonHistologicTumorFluorescenceFluorescence ImagingRodentMalignant NeoplasmsBindingAnatomyFirst-In-HumanFluorescence-Guided SurgeryClinical ResearchOperationTechnologySpecimenLocationFamily SuidaeClinical TrialsLabelBase
Grant awards (15)
Real-Time Diagnosis of Life-Threatening Necrotizing Soft-Tissue Infections Using Indocyanine Green Kinetic Modeling$710,018
R01 · FY2025 · AI · contact PI
First-in-Human Clinical Translation of a Near-Infrared, Nerve-Specific Fluorophore to Facilitate Tissue-Specific Fluorescence-Guided Surgery$402,132
R01 · FY2025 · NS · contact PI
First-in-Human Clinical Translation of a Near-Infrared, Nerve-Specific Fluorophore to Facilitate Tissue-Specific Fluorescence-Guided Surgery$402,162
R01 · FY2023 · NS · contact PI
Administrative Supplement - First-in-human clinical translation of a near-infrared, nerve-specific fluorophore to facilitate tissue-specific fluorescence-guided surgery$146,100
R01 · FY2023 · NS · contact PI
First-in-human clinical translation of a near-infrared, nerve-specific fluorophore to facilitate tissue-specific fluorescence-guided surgery$589,567
R01 · FY2022 · NS · contact PI
First-in-human clinical translation of a near-infrared, nerve-specific fluorophore to facilitate tissue-specific fluorescence-guided surgery$607,951
R01 · FY2021 · NS · contact PI
Multimodal Fluorescence- and Imaging-Guided Surgical Navigation: Developing Methods for Subsurface, Indirect Visualization of Cancers Requiring Wide Local Excision$169,727
K23 · FY2021 · EB · contact PI
First-in-human clinical translation of a near-infrared, nerve-specific fluorophore to facilitate tissue-specific fluorescence-guided surgery$620,782
R01 · FY2020 · NS · contact PI
Multimodal Fluorescence- and Imaging-Guided Surgical Navigation: Developing Methods for Subsurface, Indirect Visualization of Cancers Requiring Wide Local Excision$169,555
K23 · FY2020 · EB · contact PI
Multimodal Fluorescence- and Imaging-Guided Surgical Navigation: Developing Methods for Subsurface, Indirect Visualization of Cancers Requiring Wide Local Excision$169,736
K23 · FY2019 · EB · contact PI
Multimodal Fluorescence- and Imaging-Guided Surgical Navigation: Developing Methods for Subsurface, Indirect Visualization of Cancers Requiring Wide Local Excision$128,652
K23 · FY2018 · EB · contact PI
Development of Near-Infrared Molecular Surgical Imaging for Sarcoma Margin Definition$48,600
R03 · FY2018 · CA · contact PI
Multimodal Fluorescence- and Imaging-Guided Surgical Navigation: Developing Methods for Subsurface, Indirect Visualization of Cancers Requiring Wide Local Excision$41,100
K23 · FY2018 · EB · contact PI
Development of Near-Infrared Molecular Surgical Imaging for Sarcoma Margin Definition$32,400
R03 · FY2018 · CA · contact PI
Development of Near-Infrared Molecular Surgical Imaging for Sarcoma Margin Definition$81,000
R03 · FY2017 · CA · contact PI